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Myeloid-derived suppressor cells (MDSC) promote
tumor growth by inhibiting T cell immunity and sup-
porting malignant cell proliferation and migration. The
therapeutic potential of blocking MDSC in tumors has
been limited by their heterogeneity, plasticity, and resis-
tance to various chemotherapy agents. Recent studies
have highlighted the role of energy metabolic pathways
in the differentiation and function of immune cells;
however, the metabolic characteristics regulating MDSC
remain unclear. We aimed to determine the energy
metabolic pathway(s) used by MDSC, establish its
impact on MDSC function, and test whether its inhibi-
tion blocks MDSC and enhances anti-tumor therapies.
Using several murine tumor models, we found that
tumor-infiltrating MDSC (T-MDSC) increased fatty acid
uptake and activated fatty acid oxidation (FAO). This
was accompanied by an increased mitochondrial mass,
upregulation of key FAO enzymes, and increased oxygen
consumption rate. Pharmacological inhibition of FAO
blocked immune inhibitory pathways and functions in
T-MDSC and decreased their production of inhibitory
cytokines. FAO inhibition alone significantly delayed
tumor growth in a T cell-dependent manner and
enhanced the anti-tumor effect of adoptive T cell ther-
apy. Furthermore, FAO inhibition combined with low-
dose chemotherapy completely inhibited T-MDSC
immunosuppressive effects and induced a significant
anti-tumor effect. Interestingly, a similar increase in fatty
acid uptake and expression of FAO-related enzymes was
found in human MDSC in peripheral blood and tumors.
These results support the possibility of testing FAO inhi-
bition as a novel approach to block MDSC and enhance
various cancer therapies.
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